The Line Up Is In!
Take a Look at the TCT 2016 Late-Breaking Clinical Trials, First Report Investigations,
and Featured Clinical Research
From among the many high-quality submissions, TCT has chosen 11 Late-Breaking Clinical Trials, 16 First Report Investigations, and 15 Featured Clinical Research Studies. Don't miss these valuable findings that can have a significant impact on your patient care and your approach to treating cardiovascular disease.
Here’s just a sampling of what you can look forward to:
- EXCEL: A Prospective, Randomized Trial Comparing Everolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease.
- NOBLE: A Prospective, Randomized Trial Comparing Biolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease.
- SENTINEL: A Prospective, Randomized Trial Evaluating Cerebral Protection in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.
- BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients With Coronary Artery Disease.
- PARTNER I FIVE-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Aortic Stenosis.
|
DATES TO REMEMBER
